Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global pharma companies record sales declines. But that growth may be short ...

Whatever you do, don’t call it a festival. There’s no set schedule or events during the two-day gathering, warns Dave Shenkman, owner of Kite Connection on the Huntington Beach Pier and ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

Leading players like Sun Pharma, Syngene, Senores, and Zydus have all made strategic purchases, reflecting a broader industry shift. Analysts and insiders see this trend as a move to scale ...

Small-cap stock below ₹50: Pharma stock , Sudarshan Pharma lndustries jumps 6% from today's low in the stock market today on this acquisition buzz Sudarshan Pharma lndustries share price that ...

OKYO Pharma (OKYO) announces the filing of its application for Fast Track designation, FTD, with the U.S. Food and Drug Administration, FDA, for urcosimod for the treatment of neuropathic corneal ...

Generic injectable-focused Gland Pharma facility in Visakhapatnam has been issued three observations by the U.S. Food and Drug Administration (U.S. FDA). U.S. FDA issues 3 observations to Gland ...

Healthcare & Pharmaceuticalscategory Exclusive: Gates warns White House he can't fill shortfalls in US global health funding March 18, 2025 Healthcare & Pharmaceuticalscategory Big pharma fears ...

Stephen Ubl, CEO of the pharma lobby group Pharmaceutical Research and Manufacturers of America (PhRMA), also attended the meeting.

Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.

GAITHERSBURG, Md., March 13, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company ...